Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Annuska Strunk"'
Autor:
Annuska Strunk, Andre Abbes, Antoine R. Stuitje, Chris Hettinga, Eline Sepers, Reinier Snetselaar, Jan Schouten, Fay-Lynn Asselman, Inge Cuppen, Henny Lemmink, W. Ludo van der Pol, Henk Engel
Publikováno v:
International Journal of Neonatal Screening, Vol 5, Iss 2, p 21 (2019)
The MC002 test showed the feasibility and accuracy of SMA screening in a neonatal screening program.
Externí odkaz:
https://doaj.org/article/1814238f0f25420e9cf2c3434fd5437d
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 77:2-7
Background: Hb-variant interference when reporting HbA1c has been an ongoing challenge since HbA1c was introduced to monitor patients with diabetes mellitus. Most Hb-variants show an abnormal chromatogram when cation-exchange HPLC is used for the det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e6cf7bed4b87e883b8c463d2118cc50
https://doi.org/10.1080/00365513.2016.1183261
https://doi.org/10.1080/00365513.2016.1183261
Autor:
Andre P. Abbes, Theresia M. Westers, Arjan A. van de Loosdrecht, Annuska Strunk, Guus Westra, Martine E.D. Chamuleau, Pino J. Poddighe, Tom G. H. Wiggers, Ellen Kuiper-Kramer
Publikováno v:
Cytometry Part B: Clinical Cytometry. 86:280-287
The strongest prognostic factor in chronic B-cell lymphocytic leukemia (CLL) is the mutational status of the immunoglobulin heavy chain variable region (IGHV) genes. Determination of this mutational status is laborious and therefore not applied in ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f337954d6925325c34cc8afb8942d13
https://doi.org/10.1002/cyto.b.21132
https://doi.org/10.1002/cyto.b.21132
Autor:
Tom G H, Wiggers, Guus, Westra, Theresia M, Westers, Andre P, Abbes, Annuska, Strunk, Ellen, Kuiper-Kramer, Pino, Poddighe, Arjan A, van de Loosdrecht, Martine E D, Chamuleau
Publikováno v:
Cytometry. Part B, Clinical cytometry.
The strongest prognostic factor in chronic B-cell lymphocytic leukaemia (CLL) is the mutational status of the immunoglobulin heavy chain variable region (IGHV) genes. Determination of this mutational status is laborious and therefore not applied in r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6dc074d4687459a557303443d13ec290
https://pubmed.ncbi.nlm.nih.gov/24124110
https://pubmed.ncbi.nlm.nih.gov/24124110
Autor:
Martin J. W. IJsseldijk, Andre P. Abbes, Ellen C. Dompeling, Henk Engel, Annuska Strunk, Bert Dikkeschei, Robbert J. Slingerland, Jasper A. Remijn, Philip G. de Groot
Publikováno v:
Clinical Chemical Laboratory Medicine. 45
Background: The platelet adenosine 5'-diphosphate (ADP) receptor P2Y 12 plays a crucial role in haemostasis. Only a few patients with haemorrhagic diathesis due to molecular defects in the P2Y 12 receptor have been described so far. We report a novel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abb78ee6326185298608a240cf9cdbdb
https://doi.org/10.1515/cclm.2007.036
https://doi.org/10.1515/cclm.2007.036